Skip to content
healthcare.dev
Get a free key

TERBINAFINE HYDROCHLORIDE

NDC 69097-731, Terbinafine Tablets 250 mg, tablet, from Cipla USA Inc..

Product NDC
69097-731
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077137
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-731 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERBINAFINE HYDROCHLORIDE250 mg/1

Pharmacologic classes

Allylamine Antifungal [EPC]; Allylamine [CS]

Package NDCNDC-11Package
69097-731-026909707310230 TABLET in 1 BOTTLE (69097-731-02)
69097-731-0769097073107100 TABLET in 1 BOTTLE (69097-731-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/daf41866-6f2b-4483-b575-456becd6e85f

Use it

Look up 69097-731 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-731 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.